OncoCell MDx raises $22.2m for liquid biopsy immunogenomics platform

OncoCell MDx, a Michigan-based immugenomics platform company, which is focused on developing noninvasive blood-based diagnostic tests, has secured $22.2 million in a Series B financing ... Read More